Thibaud Derippe

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Inserm(Current)

Institut de Relations Internationales et Stratégiques

Thibaud Derippe is an author at Inserm specializing in cytotoxic t lymphocyte responses, pharmacokinetics of immunotherapies, and cancer immunotherapy.

ORCID

Publications per year

2022–2022

Publications

Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia

Sandra Dupouy, Ibtissam Marchiq, Thibaud Derippe et al. · Cancer Research Communications · 2022 · 22 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia

Thibaud Derippe, Sylvain Fouliard, Ibtissam Marchiq et al. · Cancer Research Communications · 2022 · 17 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +16

1–2 of 2